SCHEMBL14924966

SCHEMBL14924966

Cc1cc(C)c(C(C)C)cc1C(=O)NNC(=O)Nc1ccc(CN2CCOCC2)cc1

nearest known ligand 0.57

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 5/20 0.51
NPC1 O15118 5/20 0.51
SMN1; SMN2 Q16637 4/20 0.51
KMT2A Q03164 1/20 0.51
MAPK1 P28482 3/20 0.50
MAPT P10636 2/20 0.50
LMNA P02545 2/20 0.50
ALDH1A1 P00352 1/20 0.50
GAA P10253 1/20 0.50
TSHR P16473 1/20 0.50
STAT3 P40763 1/20 0.50
CACNA1B Q00975 1/20 0.50
APBA1 Q02410 1/20 0.50
SAE1 Q9UBE0 1/20 0.50
UBA2 Q9UBT2 1/20 0.50
HIF1A Q16665 4/20 0.49
EPAS1 Q99814 4/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14924915 0.91 ALDH1A1 (0.54) RAB9ANPC1SMN1; SMN2KMT2AMAPK1
SCHEMBL14924960 0.86 ALDH1A1 (0.54) RAB9ANPC1SMN1; SMN2KMT2AMAPK1
SCHEMBL14924985 0.81 NPC1 (0.48) RAB9ANPC1SMN1; SMN2KMT2AMAPK1
SCHEMBL14924983 0.80 MEN1 (0.49) RAB9ANPC1KMT2AALDH1A1
SCHEMBL5003467 0.80 CACNA1B (0.48) RAB9ANPC1SMN1; SMN2KMT2AMAPK1
SCHEMBL21644604 0.77 NPC1 (0.57) RAB9ANPC1SMN1; SMN2KMT2AMAPK1
SCHEMBL14924911 0.77 ALDH1A1 (0.58) RAB9ANPC1SMN1; SMN2KMT2AMAPK1
SCHEMBL5002692 0.75 KMT2A (0.54) RAB9ANPC1SMN1; SMN2KMT2AMAPK1
SCHEMBL14924932 0.73 MAPT (0.51) RAB9ANPC1SMN1; SMN2KMT2AMAPK1
SCHEMBL5002691 0.73 MAPK1 (0.51) SMN1; SMN2KMT2AMAPK1MAPTLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20130116431-A1 Novel HSP90 Inhibitor NIPPON KAYAKU KABUSHIKI KAISHA (JP) 2013-05-09 US disclosed
US-20130116251-A1 Novel HSP90 Inhibitor NIPPON KAYAKU KABUSHIKI KAISHA (JP) 2013-05-09 US disclosed
US-20130116253-A1 Novel HSP90 Inhibitor NIPPON KAYAKU KABUSHIKI KAISHA (JP) 2013-05-09 US disclosed
US-20130116252-A1 Novel HSP90 Inhibitor NIPPON KAYAKU KABUSHIKI KAISHA (JP) 2013-05-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130116252-A1 Novel HSP90 Inhibitor HSP90AB1, HSP90AB2P, HSP90B1 RAB9A 2218/4885NPC1 1521/4885SMN1; SMN2 4619/4885
US-20130116253-A1 Novel HSP90 Inhibitor HSP90AB1, HSP90AB2P, HSP90B1 RAB9A 2218/4885NPC1 1521/4885SMN1; SMN2 4619/4885
US-20130116251-A1 Novel HSP90 Inhibitor HSP90AB1, HSP90AB2P, HSP90B1 RAB9A 2218/4885NPC1 1521/4885SMN1; SMN2 4619/4885
US-20130116431-A1 Novel HSP90 Inhibitor HSP90AB1, HSP90AB2P, HSP90B1 RAB9A 2218/4885NPC1 1521/4885SMN1; SMN2 4619/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.